Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Somers

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYan Helen Hu, Elizabeth Somers, Miyuru Amarapala, et al.
Australian and New Zealand Journal of Public Health|December 8, 2010
A holistic client-centred program for vulnerable frequent hospital attenders: cost efficiencies and changed practicesKaren Grimmer-Somers, Kylie Johnston, Elizabeth Somers, et al.
Clinical and Translational Medicine|June 29, 2021
Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancerHitomi Sakai, Hisato Kawakami, Takeshi Teramura, et al.
Gynecologic Oncology|May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragmentDonna Badgwell, Zhen Lu, Laurence Cole, et al.
Nature Reviews. Neurology|June 12, 2024
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's DiseaseSuzanne E Schindler, Douglas Galasko, Ana C Pereira, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYan Helen Hu, Elizabeth Somers, Miyuru Amarapala, et al.
Australian and New Zealand Journal of Public Health|December 8, 2010
A holistic client-centred program for vulnerable frequent hospital attenders: cost efficiencies and changed practicesKaren Grimmer-Somers, Kylie Johnston, Elizabeth Somers, et al.
Clinical and Translational Medicine|June 29, 2021
Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancerHitomi Sakai, Hisato Kawakami, Takeshi Teramura, et al.
Gynecologic Oncology|May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragmentDonna Badgwell, Zhen Lu, Laurence Cole, et al.
Nature Reviews. Neurology|June 12, 2024
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's DiseaseSuzanne E Schindler, Douglas Galasko, Ana C Pereira, et al.
Pageof 1